Market Analysis
Why Is RAPT Stock Skyrocketing Today? GSK’s $2.2B Offer Drives Rally
RAPT Therapeutics stock surged over 63% after GSK agreed to buy the company for $58 per share in a $2.2 billion deal.
Total Stories
2,790
News
Market Analysis
Section
Market Analysis
Market Analysis
From $103 to $365: Why Micron’s AI-Fueled Rally Still Has Room to Run
Despite surpassing its average analyst price target, Micron’s forward valuation and memory bottleneck economics point toward a credible path to $500 by 2026.
Market Analysis
Watch these 3 Stocks for Significant Potential Gains in 2026
With risk assets retreating and commodities exploding higher, investors are hunting for durable growth stories trading below consensus value.
Market Analysis
Why Are IBRX Shares Up in Premarket? FDA Feedback Boosts ANKTIVA
ImmunityBio shares jumped in premarket trading after the FDA outlined next steps for expanding ANKTIVA’s bladder cancer label.
Market Analysis
Critical Metals Stock Jumps Premarket as Greenland Tensions Return to Headlines
Critical Metals stock jumped in premarket trading as fresh headlines around Greenland reignited investor interest in the company’s Tanbreez rare earths project.
Market Analysis
State Street Drops After Q4 Results: Beat on Paper, But Costs Raise Questions
State Street shares slipped after the bank posted a Q4 earnings and revenue beat, but investors focused on restructuring costs and a higher-than-expected expense outlook for…
Market Analysis
Why Is QXO Stock Down in Premarket Today? Public Offering Details Announced
QXO stock declined over 6% in premarket trading after announcing a 31.6 million share offering priced at $23.80, below its previous close.
Market Analysis
Regions Financial (RF) Stock Slides After Q4 Earnings Miss Estimates
Regions Financial shares fell sharply in premarket trading after the bank reported fourth-quarter earnings that came in below Wall Street expectations.
Market Analysis
Why Is ImmunityBio (IBRX) Stock Up Premarket? ANKTIVA Sales Jump 700%
ImmunityBio stock jumped after the company reported preliminary 2025 net product revenue of $113 million, up about 700% year over year.
Market Analysis
Why Are Morgan Stanley Shares Rising? Q4 Profit Tops Estimates
Morgan Stanley stock rose over 4% after the bank beat Q4 estimates, posting $2.68 EPS on $17.89 billion in revenue as investment banking revenue jumped 47%.
Market Analysis
Financial Heavyweights Earnings Face Off: JPM vs. BAC vs. WFC
With financials outperforming in the past year, we analyze the largest KBWB constituents to determine which bank combines earnings strength with the highest upside potential.
Market Analysis
BSX Shares Dip as Boston Scientific Unveils Biggest Deal in 20 Years
Boston Scientific stock slipped 3.6% in premarket trading after the company announced a $14.5 billion deal to buy Penumbra.
Market Analysis
Why Is Ocular Therapeutix (OCUL) Stock Up Premarket Today? Sanofi Bid Rejection Fuels Rally
Ocular Therapeutix stock jumped over 18% in premarket trading after rejecting Sanofi’s $16 per share buyout offer, as investors turned bullish on the company’s late-stage pipeline.